ArticleClinical research in cardiology : official journal of the German Cardiac Society2026
Implementation of revascularization guidelines for diabetics with chronic coronary syndromes in clinical practice: findings from the German ALKK registry.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe German National Care Guideline for chronic coronary syndromes (CCS) and the European Society of Cardiology (ESC) guidelines on the management of CCS recommend coronary artery bypass grafting (CABG) for patients with diabetes and multivessel coronary artery disease (MVD). There are limited data on how these recommendations are followed in routine clinical practice.
methodsConsecutive patients with CCS who underwent diagnostic coronary angiography (CA) between 2009 and 2020 were prospectively enrolled within the German CA registry by the "Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte" (ALKK). Patients with acute coronary syndromes were excluded.
resultsA total of 245,555 patients without prior CABG undergoing CA for CCS were included. In patients with 3-vessel disease, PCI was recommended in 62.2% of diabetics versus 63.8% of non-diabetics, CABG in 19.4% versus 18.8%, and conservative treatment in 18.4% versus 17.4%. In multivariable analysis, 3-vessel disease (odds ratio (OR) 4.01, 95% confidence interval (CI), 2.72-5.92) and left main disease (OR 14.64, 95% CI, 10.51-12.40) emerged as the strongest predictors for recommending CABG, whereas the presence of diabetes had no significant influence (OR 1.09, 95% CI, 0.98-1.21).
conclusionIn real-world clinical practice, PCI remains the predominant revascularization strategy for MVD in patients with diabetes and CCS. Coronary anatomy, rather than diabetic status, is the principal determinant for the decision for CABG. These findings contrast with the recommendations in current national and international revascularization guidelines.
Indexed as
Identifiers
41524748What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.